These data suggest that NEK2 may provide an ideal mitotic target for potentiating the efficacy of CDK4/6i and expanding their use in TNBC by promoting CIN and inducing mitotic cell death. Here, NEK2 is linked to cervical squamous intraepithelial neoplasia.